References
- 1. Elias MF, Goodell AL, Dore GA. Hypertension and cognitive functioning: A perspective in historical context. Hypertension. 2012;60(2):260–8.10.1161/HYPERTENSIONAHA.111.18642922753214
- 2. Kilander L, Nyman H, Boberg M, et al. A 20-Year Follow-up of 999 Men. Hypertension. 1998;31:780–7.10.1161/01.HYP.31.3.7809495261
- 3. Elias PK, Elias MF, D’Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance: The Framingham Study. Diabetes Care.1997;20(9):1388–95.10.2337/diacare.20.9.13889283785
- 4. Stewart R, Xue QL, Masaki K, et al. Change in blood pressure and incident dementia: A 32-year prospective study. Hypertension. 2009;54(2):233–40.10.1161/HYPERTENSIONAHA.109.128744313604019564551
- 5. Gelber PR, Launer JL, White LR. The honolulu-asia aging study: Epidemiologic and neuropathologic research on cognitive impairment. Curr Alzheimer Res.2012;9(6):664–72.10.2174/156720512801322618479593922471866
- 6. Lin JS, O’Connor E, Rossom RC. Screening for Cognitive Impairment in Older Adults: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;159(9).10.7326/0003-4819-159-9-201311050-0073024145578
- 7. Mancia G, Spiering W, Rosei EA, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J.2018; 3021-3104.
- 8. Larner A. Cognitive Screening Instruments. A practical approach. Liverpool. Springer. 2013;15-17, 111-114, 201-202.
- 9. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–962.10.1093/eurheartj/ehw21027567408
- 10. Iadecola C, Yaffe K, Biller J, et al. Impact of Hypertension on Cognitive Function: A Scientific Statement from the American Heart Association. Hypertension. 2016;68(6):67–94.10.1161/HYP.0000000000000053536141127977393
- 11. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672–713.10.1161/STR.0b013e3182299496377866921778438
- 12. Vermeer SH, Prins ND, den Heijer T, et al. Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline. N Engl J Med. 2003;1215–22.10.1056/NEJMoa02206612660385
- 13. Smith EE, Saposnik G, Biessels GJ, et al. Prevention of Stroke in Patients with Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48, 44-71.10.1161/STR.0000000000000116
- 14. Hénon H, Pasquier F, Leys D. Poststroke dementia. Cerebrovasc Dis. 2006;22:61–70.10.1159/00009292316645268
- 15. Douiri A, Rudd AG, Wolfe CDA. Prevalence of poststroke cognitive impairment: South London stroke register 1995-2010. Stroke. 2013;44(1):138–45.10.1161/STROKEAHA.112.67084423150656
- 16. Sun J-H, Tan L, Yu J-T. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med. 2014;2(8):80.
- 17. Knecht S, Oelschläger C, Duning T, et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J. 2008;29(17):2125–32.10.1093/eurheartj/ehn34118667399
- 18. Ott A, Breteler MMB, de Bruyne MC, et al. A. Atrial Fibrillation and Dementia in a Population-Based Study. Stroke. 1997;28(2):316-321.10.1161/01.STR.28.2.3169040682
- 19. Hendriks JM, Gallagher C, Middeldorp ME, et al. New approaches to detection of atrial fibrillation. Heart. 2018;0:1-2.10.1136/heartjnl-2018-31342329925541